PSA Screening and Prostate Cancer Mortality

被引：0
|
作者：
D'Amico, Anthony V. [1 ]
机构：
[1] Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年
关键词：
D O I：
10.1001/jama.2024.13803
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prostate cancer and prostate specific antigen (PSA) screening in Austria
    Vutuc, C
    Schernhammer, ES
    Haidinger, G
    Waldhör, T
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (13-14) : 457 - 461
  • [42] PROSTATE SPECIFIC ANTIGEN (PSA)-PYRAMID IN MEN WITH LOW RANGE PSA: PROSTATE CANCER INCIDENCE AND MORTALITY - A PLEA FOR RISK-BASED PROSTATE CANCER SCREENING STRATEGY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC), AARAU
    Randazzo, Marco
    Seiler, Daniel
    Beatrice, Josef
    Baumgartner, Martin
    Huber, Andreas
    Grobholz, Rainer
    Manka, Lukas
    Ahyai, Sascha
    Chun, Felix
    Recker, Franz
    Kwiatkowski, Maciej
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E793 - E793
  • [43] Prostate cancer and prostate-specific antigen (PSA) screening in AustriaProstatakarzinom und PSA-Screening in Österreich
    Christian Vutuc
    Eva S. Schernhammer
    Gerald Haidinger
    Thomas Waldhör
    [J]. Wiener klinische Wochenschrift, 2005, 117 : 457 - 461
  • [44] Does the PSA-screening influence the mortality of prostate carcinoma?
    Krome, Susanne
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (21) : 1098 - 1098
  • [45] Prostate cancer screening and mortality
    Bangma, Chris H.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 7 - 7
  • [46] Prostate cancer mortality and screening
    Oliver, SE
    [J]. PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE, 2003, : 267 - 273
  • [47] Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality
    Dahm, Philipp
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 156 (08)
  • [48] Impact of PSA screening on mortality - PLCO Project Team (Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial)
    Heidenreich, A.
    Nitschmann, S.
    [J]. INTERNIST, 2010, 51 (02): : 219 - 220
  • [49] Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening REPLY
    Soerensen, Simon John Christoph
    Thomas, I-Chun
    Schmidt, Bogdana
    Daskivich, Timothy J.
    Skolarus, Ted A.
    Jackson, Christian
    Osborne, Thomas F.
    Chertow, Glenn M.
    Brooks, James D.
    Rehkopf, David H.
    Leppert, John T.
    [J]. UROLOGY, 2021, 155 : 76 - 76
  • [50] Re: Reconsidering Prostate Cancer Mortality- The Future of PSA Screening Against increasing PSA threshold to 10 ng/ml
    Zlotta, Alexandre R.
    Carlsson, Sigrid V.
    Finelli, Antonio
    Fleshner, Neil E.
    [J]. EUROPEAN UROLOGY, 2020, 78 (06) : 927 - 929
12345